The relation between GABA and L-Arginine levels with some stroke risk factors in acute ischemic stroke patients

International Journal of Molecular and Cellular Medicine

Volumn 5, Issue 2, 2016, Pages 100-105

  Hosinian, Mohsen ^a   Qujeq, Durdi ^a   Ahangar, Alijan Ahmadi ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute ischemic stroke; Arginine; Gamma aminobutyric acid (GABA)

Indexed keywords

EID: 85021941896     PISSN: 22519637     EISSN: 22519645     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nature reviews Neuroscience 2005;6:215-29.
2. Szabadics J, Varga C, Molnar G, et al. Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits. Science 2006;311:233-5.
3. Watanabe M, Maemura K, Kanbara K, et al. GABA and GABA receptors in the central nervous system and other organs. International review of cytology 2002;213:1-47.
4. Camacho A, Massieu L. Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Archives of medical research 2006;37:11-8.
5. Mergenthaler P, Dirnagl U, Meisel A. Pathophysiology of stroke: lessons from animal models. Metabolic brain disease 2004;19:151-67.
6. Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000;403:316-21.
7. Besancon E, Guo S, Lok J, et al. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends in pharmacological sciences 2008;29:268-75.
8. Skvortsova VI, Raevskii KS, Kovalenko AV, et al. Levels of neurotransmitter amino acids in the cerebrospinal fluid of patients with acute ischemic insult. Neuroscience and behavioral physiology 2000;30:491-5.
9. Brouns R, Van Hemelrijck A, Drinkenburg WH, et al. Excitatory amino acids and monoaminergic neurotransmitters in cerebrospinal fluid of acute ischemic stroke patients. Neurochemistry international 2010;56:865-70.
10. Davalos A, Shuaib A, Wahlgren NG. Neurotransmitters and pathophysiology of stroke: evidence for the release of glutamate and other transmitters/mediators in animals and humans. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association 2000;9:2-8.
11. Hutchinson PJ, O'Connell MT, Al-Rawi PG, et al. Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids. Journal of neurology, neurosurgery, and psychiatry 2002;72:99-105.
12. Liu J, Wang LN. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. The Cochrane database of systematic reviews 2014:CD009622.
13. Jia J, Hu YS, Wu Y, et al. Pre-ischemic treadmill training affects glutamate and gamma aminobutyric acid levels in the striatal dialysate of a rat model of cerebral ischemia. Life sciences 2009;84:505-11.
14. Hiu T, Farzampour Z, Paz JT, et al. Enhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic target. Brain: a journal of neurology 2016;139:468-80.
15. Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke; a journal of cerebral circulation 1997;28:1283-8.
16. Zhang G, Bown AW. The rapid determination of +-aminobutyric acid. Phytochem 1997;44:1007 -9.
17. Satake K, Luck JM. The spectrophotometric determination of arginine by the Sakaguchi reaction. Bulletin de la Societe de chimie biologique 1958;40:1743-56.
18. Blicher JU, Near J, Naess-Schmidt E, et al. GABA levels are decreased after stroke and GABA changes during rehabilitation correlate with motor improvement. Neurorehabilitation and neural repair 2015;29:278-86.
19. Schwartz-Bloom RD, Sah R. gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia. Journal of neurochemistry 2001;77:353-71.
20. Yazdanparast R, Qujeq D. Significant changes in the activity of L-glutamic acid decarboxylase of mouse hypothalamus after peripheral injection of cholecystokinin-8 and caerulein. Iranian biomedical journal 1999;3:47-51.
21. Castillo J, Rama R, Davalos A. Nitric oxide-related brain damage in acute ischemic stroke. Stroke; a journal of cerebral circulation 2000;31:852-7.
22. Armengou A, Hurtado O, Leira R, et al. L-arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke: a clinical and experimental study. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 2003;23:978-84.
23. Rashid PA, Whitehurst A, Lawson N, et al. Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relationship with severity and outcome. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association 2003;12:82-7.
24. Molnar T, Pusch G, Nagy L, et al. Correlation of the LArginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association 2016.
25. Molnar T, Pusch G, Papp V, et al. The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association 2014;23:2206-14.
26. van Waardenburg DA, de Betue CT, Luiking YC, et al. Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation. The American journal of clinical nutrition 2007;86:1438-44.
27. Belelli D, Harrison NL, Maguire J, et al. Extrasynaptic GABAA receptors: form, pharmacology, and function. The Journal of neuroscience: the official journal of the Society for Neuroscience 2009;29:12757-63.
28. Grupke S, Hall J, Dobbs M, et al. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview. Clinical neurology and neurosurgery 2015;129:1-9.